WEXFORD CAPITAL LP sold NEPH
August 18, 2026 · Form 4 insider transaction
WEXFORD CAPITAL LP sold 3,765 shares of Nephros, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,765
Price
$0.00
Total value
N/A
InsiderWEXFORD CAPITAL LP
RoleDirector, 10% owner
CompanyNephros, Inc. (NEPH)
SecurityStock Option (Right to Buy)
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after36,198
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third of the options vested immediately upon the grant date of August 24, 2016. The remainder of the options vested in equal annual installments on each of the first and second anniversaries of the grant date.; Includes stock options granted to Wexford Capital as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.